- Part 30: For the preceding part double click ID:nRSH4027RC
control could result in the failure of the supply of goods and services.
For example, suppliers of key goods may cease to trade or experience
supply chain failures such as those described under the risk above. In
addition, we may experience limited supply of biological materials, such
as cells, animal products or by-products. Furthermore, government
regulations could result in restricted access to, use or transport of
such materials. Manufacturing biologicsManufacturing biologics,
especially in large quantities, is complex and may require the use of
innovative technologies to handle living micro-organisms and facilities
specifically designed and validated for this purpose, with sophisticated
quality assurance and control procedures.Final market release of a
biologic depends on a number of in-process manufacturing and supply chain
- More to follow, for following part double click ID:nRSH4027RE